India has a huge patient burden of rheumatic diseases (RD s) including rheumatoid arthritis.
The use of biologics has transformed the treatment paradigm for RD; however, biologic …

The practice of rheumatology in a country like India presents its own unique challenges,
including the need to manage patients in a cost-constrained setting, where the lack of …

We present a case of pleural tuberculosis (TB) in a patient on infliximab for ankylosing
spondylitis. A 36‑year‑old male presented to our hospital with low back ache of inflammatory …

Objective. To test the efficacies of a strategy for preventing tuberculosis (TB) in Indian
patients with inflammatory rheumatic diseases (IRD) treated with tumor necrosis factor-α …

Abstract Aims: To review the Indian experience with anti‐tumor necrosis factor (TNF)‐α
therapy. Methods:'PubMed'and 'IndMED'were searched for Indian studies on anti‐TNF‐α …

India is home to a large patient population of both rheumatoid arthritis (RA) and tuberculosis
(TB). As the usage of biologic agents in RA increases in India, the issue of TB reactivation …

Psoriatic arthritis (PsA) is a chronic inflammatory disease that can be progressive and may
be associated with permanent joint damage and disability. Early identification of PsA will …

Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy has revolutionized the treatment of
inflammatory diseases, such as psoriasis and psoriatic arthritis. However, a major concern is …

Patients with autoimmune inflammatory rheumatic disorders have a higher incidence of
infections indicative of inher-ent immunosuppressed state related to the disease activity. The …

The era of biologic therapy has been a major breakthrough recently in the field of
rheumatology particularly in RA. Experience with these agents in Indian patients is scanty …